[1]
Tagaya Y, Matsuoka M, Gallo R. 40 years of the human T-cell leukemia virus: past, present, and future. F1000Research. 2019:8():. pii: F1000 Faculty Rev-228. doi: 10.12688/f1000research.17479.1. Epub 2019 Feb 28
[PubMed PMID: 30854194]
[2]
Nejmeddine M, Barnard AL, Tanaka Y, Taylor GP, Bangham CR. Human T-lymphotropic virus, type 1, tax protein triggers microtubule reorientation in the virological synapse. The Journal of biological chemistry. 2005 Aug 19:280(33):29653-60
[PubMed PMID: 15975923]
[4]
Majorovits E,Nejmeddine M,Tanaka Y,Taylor GP,Fuller SD,Bangham CR, Human T-lymphotropic virus-1 visualized at the virological synapse by electron tomography. PloS one. 2008 May 28;
[PubMed PMID: 18509526]
[5]
Bindhu M, Nair A, Lairmore MD. Role of accessory proteins of HTLV-1 in viral replication, T cell activation, and cellular gene expression. Frontiers in bioscience : a journal and virtual library. 2004 Sep 1:9():2556-76
[PubMed PMID: 15358581]
[6]
Gross C, Thoma-Kress AK. Molecular Mechanisms of HTLV-1 Cell-to-Cell Transmission. Viruses. 2016 Mar 9:8(3):74. doi: 10.3390/v8030074. Epub 2016 Mar 9
[PubMed PMID: 27005656]
[7]
Mazurov D, Ilinskaya A, Heidecker G, Lloyd P, Derse D. Quantitative comparison of HTLV-1 and HIV-1 cell-to-cell infection with new replication dependent vectors. PLoS pathogens. 2010 Feb 26:6(2):e1000788. doi: 10.1371/journal.ppat.1000788. Epub 2010 Feb 26
[PubMed PMID: 20195464]
[8]
Giam CZ, Semmes OJ. HTLV-1 Infection and Adult T-Cell Leukemia/Lymphoma-A Tale of Two Proteins: Tax and HBZ. Viruses. 2016 Jun 16:8(6):. doi: 10.3390/v8060161. Epub 2016 Jun 16
[PubMed PMID: 27322308]
[9]
Nakano K, Watanabe T. HTLV-1 Rex: the courier of viral messages making use of the host vehicle. Frontiers in microbiology. 2012:3():330. doi: 10.3389/fmicb.2012.00330. Epub 2012 Sep 6
[PubMed PMID: 22973269]
[10]
Fuentes-González AM, Contreras-Paredes A, Manzo-Merino J, Lizano M. The modulation of apoptosis by oncogenic viruses. Virology journal. 2013 Jun 6:10():182. doi: 10.1186/1743-422X-10-182. Epub 2013 Jun 6
[PubMed PMID: 23741982]
[11]
Nosaka K, Iwanaga M, Imaizumi Y, Ishitsuka K, Ishizawa K, Ishida Y, Amano M, Ishida T, Uike N, Utsunomiya A, Ohshima K, Kawai K, Tanaka J, Tokura Y, Tobinai K, Watanabe T, Uchimaru K, Tsukasaki K. Epidemiological and clinical features of adult T-cell leukemia-lymphoma in Japan, 2010-2011: A nationwide survey. Cancer science. 2017 Dec:108(12):2478-2486. doi: 10.1111/cas.13398. Epub 2017 Oct 8
[PubMed PMID: 28905463]
Level 2 (mid-level) evidence
[12]
de Thé G, Bomford R. An HTLV-I vaccine: why, how, for whom? AIDS research and human retroviruses. 1993 May:9(5):381-6
[PubMed PMID: 8318266]
[13]
Maloney EM, Cleghorn FR, Morgan OS, Rodgers-Johnson P, Cranston B, Jack N, Blattner WA, Bartholomew C, Manns A. Incidence of HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Jamaica and Trinidad. Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association. 1998 Feb 1:17(2):167-70
[PubMed PMID: 9473019]
[14]
Tsukasaki K. Adult T-cell leukemia-lymphoma. Hematology (Amsterdam, Netherlands). 2012 Apr:17 Suppl 1():S32-5. doi: 10.1179/102453312X13336169155330. Epub
[PubMed PMID: 22507774]
[15]
Paiva AM, Assone T, Haziot MEJ, Smid J, Fonseca LAM, Luiz ODC, de Oliveira ACP, Casseb J. Risk factors associated with HTLV-1 vertical transmission in Brazil: longer breastfeeding, higher maternal proviral load and previous HTLV-1-infected offspring. Scientific reports. 2018 May 17:8(1):7742. doi: 10.1038/s41598-018-25939-y. Epub 2018 May 17
[PubMed PMID: 29773807]
[16]
Boostani R, Sadeghi R, Sabouri A, Ghabeli-Juibary A. Human T-lymphotropic virus type I and breastfeeding; systematic review and meta-analysis of the literature. Iranian journal of neurology. 2018 Oct 7:17(4):174-179
[PubMed PMID: 31210902]
Level 1 (high-level) evidence
[17]
Bartholomew C,Jack N,Edwards J,Charles W,Corbin D,Cleghorn FR,Blattner WA, HTLV-I serostatus of mothers of patients with adult T-cell leukemia and HTLV-I-associated myelopathy/tropical spastic paraparesis. Journal of human virology. 1998 May-Jun;
[PubMed PMID: 10195256]
[18]
Krämer A, Maloney EM, Morgan OS, Rodgers-Johnson P, Manns A, Murphy EL, Larsen S, Cranston B, Murphy J, Benichou J. Risk factors and cofactors for human T-cell lymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Jamaica. American journal of epidemiology. 1995 Dec 1:142(11):1212-20
[PubMed PMID: 7485068]
[19]
Murphy EL. Infection with human T-lymphotropic virus types-1 and -2 (HTLV-1 and -2): Implications for blood transfusion safety. Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine. 2016 Feb:23(1):13-9. doi: 10.1016/j.tracli.2015.12.001. Epub 2016 Jan 5
[PubMed PMID: 26778839]
[20]
Yamauchi J, Yamano Y, Yuzawa K. Risk of Human T-Cell Leukemia Virus Type 1 Infection in Kidney Transplantation. The New England journal of medicine. 2019 Jan 17:380(3):296-298. doi: 10.1056/NEJMc1809779. Epub
[PubMed PMID: 30650320]
[21]
Tajima K. Malignant lymphomas in Japan: epidemiological analysis of adult T-cell leukemia/lymphoma (ATL). Cancer metastasis reviews. 1988 Nov:7(3):223-41
[PubMed PMID: 3067901]
Level 2 (mid-level) evidence
[22]
Lee DK, Kim BC, Brady JN, Jeang KT, Kim SJ. Human T-cell lymphotropic virus type 1 tax inhibits transforming growth factor-beta signaling by blocking the association of Smad proteins with Smad-binding element. The Journal of biological chemistry. 2002 Sep 13:277(37):33766-75
[PubMed PMID: 12097320]
[23]
Kchour G, Makhoul NJ, Mahmoudi M, Kooshyar MM, Shirdel A, Rastin M, Rafatpanah H, Tarhini M, Zalloua PA, Hermine O, Farid R, Bazarbachi A. Zidovudine and interferon-alpha treatment induces a high response rate and reduces HTLV-1 proviral load and VEGF plasma levels in patients with adult T-cell leukemia from North East Iran. Leukemia & lymphoma. 2007 Feb:48(2):330-6
[PubMed PMID: 17325893]
[24]
Shah V, Bendele A, Dines JS, Kestler HK, Hollinger JO, Chahine NO, Hee CK. Dose-response effect of an intra-tendon application of recombinant human platelet-derived growth factor-BB (rhPDGF-BB) in a rat Achilles tendinopathy model. Journal of orthopaedic research : official publication of the Orthopaedic Research Society. 2013 Mar:31(3):413-20. doi: 10.1002/jor.22222. Epub 2012 Aug 29
[PubMed PMID: 22933269]
[25]
McLane LM, Abdel-Hakeem MS, Wherry EJ. CD8 T Cell Exhaustion During Chronic Viral Infection and Cancer. Annual review of immunology. 2019 Apr 26:37():457-495. doi: 10.1146/annurev-immunol-041015-055318. Epub 2019 Jan 24
[PubMed PMID: 30676822]
[26]
Pasquier A, Alais S, Roux L, Thoulouze MI, Alvarez K, Journo C, Dutartre H, Mahieux R. How to Control HTLV-1-Associated Diseases: Preventing de Novo Cellular Infection Using Antiviral Therapy. Frontiers in microbiology. 2018:9():278. doi: 10.3389/fmicb.2018.00278. Epub 2018 Mar 13
[PubMed PMID: 29593659]
[27]
Futsch N, Mahieux R, Dutartre H. HTLV-1, the Other Pathogenic Yet Neglected Human Retrovirus: From Transmission to Therapeutic Treatment. Viruses. 2017 Dec 21:10(1):. doi: 10.3390/v10010001. Epub 2017 Dec 21
[PubMed PMID: 29267225]
[28]
Nadella MV, Shu ST, Dirksen WP, Thudi NK, Nadella KS, Fernandez SA, Lairmore MD, Green PL, Rosol TJ. Expression of parathyroid hormone-related protein during immortalization of human peripheral blood mononuclear cells by HTLV-1: implications for transformation. Retrovirology. 2008 Jun 9:5():46. doi: 10.1186/1742-4690-5-46. Epub 2008 Jun 9
[PubMed PMID: 18541021]
[29]
Tsukasaki K, Hermine O, Bazarbachi A, Ratner L, Ramos JC, Harrington W Jr, O'Mahony D, Janik JE, Bittencourt AL, Taylor GP, Yamaguchi K, Utsunomiya A, Tobinai K, Watanabe T. Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: a proposal from an international consensus meeting. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2009 Jan 20:27(3):453-9. doi: 10.1200/JCO.2008.18.2428. Epub 2008 Dec 8
[PubMed PMID: 19064971]
Level 3 (low-level) evidence
[30]
Desai A, Fe A, Desai A, Ilowite J, Cunha BA, Mathew JP. A Case of Pneumonia Caused by Pneumocystis Jirovecii and Cryptococcus Neoformans in a Patient with HTLV-1 Associated Adult T- Cell Leukemia/Lymphoma: Occam's Razor Blunted. Connecticut medicine. 2016 Feb:80(2):81-3
[PubMed PMID: 27024978]
Level 3 (low-level) evidence
[31]
Kawano N, Nagahiro Y, Yoshida S, Tahara Y, Himeji D, Kuriyama T, Tochigi T, Nakaike T, Shimokawa T, Yamashita K, Ochiai H, Marutsuka K, Mashiba K, Shimoda K, Teshima T, Kikuchi I. Clinical features and treatment outcomes of opportunistic infections among human T-lymphotrophic virus type 1 (HTLV-1) carriers and patients with adult T-cell leukemia-lymphoma (ATL) at a single institution from 2006 to 2016. Journal of clinical and experimental hematopathology : JCEH. 2019:59(4):156-167. doi: 10.3960/jslrt.18032. Epub
[PubMed PMID: 31866618]
[32]
Mahieux R, Gessain A. HTLV-1 and associated adult T-cell leukemia/lymphoma. Reviews in clinical and experimental hematology. 2003 Dec:7(4):336-61
[PubMed PMID: 15129647]
[33]
Malpica L, Pimentel A, Reis IM, Gotuzzo E, Lekakis L, Komanduri K, Harrington T, Barber GN, Ramos JC. Epidemiology, clinical features, and outcome of HTLV-1-related ATLL in an area of prevalence in the United States. Blood advances. 2018 Mar 27:2(6):607-620. doi: 10.1182/bloodadvances.2017011106. Epub
[PubMed PMID: 29545256]
Level 3 (low-level) evidence
[34]
Bangham CR, Araujo A, Yamano Y, Taylor GP. HTLV-1-associated myelopathy/tropical spastic paraparesis. Nature reviews. Disease primers. 2015 Jun 18:1():15012. doi: 10.1038/nrdp.2015.12. Epub 2015 Jun 18
[PubMed PMID: 27188208]
[36]
Coler-Reilly AL, Yagishita N, Suzuki H, Sato T, Araya N, Inoue E, Takata A, Yamano Y. Nation-wide epidemiological study of Japanese patients with rare viral myelopathy using novel registration system (HAM-net). Orphanet journal of rare diseases. 2016 May 25:11(1):69. doi: 10.1186/s13023-016-0451-x. Epub 2016 May 25
[PubMed PMID: 27225443]
Level 2 (mid-level) evidence
[37]
Raza SM, Pyatt JR. Nocturnal hypertension and autonomic dysfunction due to human T-lymphotropic virus type-1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP). International journal of cardiology. 2006 Mar 8:107(3):424-6
[PubMed PMID: 16503269]
[38]
Yamano Y, Sato T. Clinical pathophysiology of human T-lymphotropic virus-type 1-associated myelopathy/tropical spastic paraparesis. Frontiers in microbiology. 2012:3():389. doi: 10.3389/fmicb.2012.00389. Epub 2012 Nov 9
[PubMed PMID: 23162542]
[39]
McGill NK, Vyas J, Shimauchi T, Tokura Y, Piguet V. HTLV-1-associated infective dermatitis: updates on the pathogenesis. Experimental dermatology. 2012 Nov:21(11):815-21. doi: 10.1111/exd.12007. Epub
[PubMed PMID: 23163646]
[40]
Kamoi K, Mochizuki M. HTLV-1 uveitis. Frontiers in microbiology. 2012:3():270. doi: 10.3389/fmicb.2012.00270. Epub 2012 Jul 24
[PubMed PMID: 22837757]
[41]
Martin F, Taylor GP, Jacobson S. Inflammatory manifestations of HTLV-1 and their therapeutic options. Expert review of clinical immunology. 2014 Nov:10(11):1531-46. doi: 10.1586/1744666X.2014.966690. Epub
[PubMed PMID: 25340428]
[42]
Einsiedel L, Fernandes L, Spelman T, Steinfort D, Gotuzzo E. Bronchiectasis is associated with human T-lymphotropic virus 1 infection in an Indigenous Australian population. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2012 Jan 1:54(1):43-50. doi: 10.1093/cid/cir766. Epub 2011 Nov 17
[PubMed PMID: 22095566]
[43]
Honarbakhsh S, Taylor GP. High prevalence of bronchiectasis is linked to HTLV-1-associated inflammatory disease. BMC infectious diseases. 2015 Jul 6:15():258. doi: 10.1186/s12879-015-1002-0. Epub 2015 Jul 6
[PubMed PMID: 26143070]
[44]
Saghafi M, Rezaieyazdi Z, Nabavi S, Mirfeizi Z, Sahebari M, Salari M. HTLV-1 seroprevalance in sarcoidosis. A clinical and laboratory study in northeast of Iran. International journal of rheumatic diseases. 2018 Jun:21(6):1309-1313. doi: 10.1111/1756-185X.13009. Epub 2017 Feb 9
[PubMed PMID: 28185411]
[45]
Peloponese JM Jr,Kinjo T,Jeang KT, Human T-cell leukemia virus type 1 Tax and cellular transformation. International journal of hematology. 2007 Aug;
[PubMed PMID: 17875521]
[46]
Bittencourt AL, Andrade AC, Requião C, Arruda MD, Araújo I. Prolonged lymphocytosis as the first manifestation of Hodgkin-like adult T-cell leukemia/lymphoma. The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases. 2017 Jan-Feb:21(1):119-122. doi: 10.1016/j.bjid.2016.09.005. Epub 2016 Oct 24
[PubMed PMID: 27789281]
[47]
Ishitsuka K, Tamura K. Human T-cell leukaemia virus type I and adult T-cell leukaemia-lymphoma. The Lancet. Oncology. 2014 Oct:15(11):e517-26. doi: 10.1016/S1470-2045(14)70202-5. Epub
[PubMed PMID: 25281470]
[48]
De Castro-Costa CM, Araújo AQ, Barreto MM, Takayanagui OM, Sohler MP, da Silva EL, de Paula SM, Ishak R, Ribas JG, Rovirosa LC, Carton H, Gotuzzo E, Hall WW, Montano S, Murphy EL, Oger J, Remondegui C, Taylor GP. Proposal for diagnostic criteria of tropical spastic paraparesis/HTLV-I-associated myelopathy (TSP/HAM). AIDS research and human retroviruses. 2006 Oct:22(10):931-5
[PubMed PMID: 17067261]
[49]
Siemieniuk RA, Fonseca K, Gill MJ. Using root cause analysis and form redesign to reduce incorrect ordering of HIV tests. Joint Commission journal on quality and patient safety. 2012 Nov:38(11):506-12
[PubMed PMID: 23173397]
Level 2 (mid-level) evidence
[50]
Nakamura D, Yoshimitsu M, Tabuchi T, Arima N, Hayashida M, Inoue H, Matsushita K, Matsumoto T, Arima N, Ishitsuka K. Treatment of aggressive adult T-cell leukemia/lymphoma: a retrospective study in a hospital located in HTLV-1 highly endemic area. International journal of hematology. 2020 Feb:111(2):234-240. doi: 10.1007/s12185-019-02769-w. Epub 2019 Nov 12
[PubMed PMID: 31721034]
Level 2 (mid-level) evidence
[51]
Sato T, Coler-Reilly ALG, Yagishita N, Araya N, Inoue E, Furuta R, Watanabe T, Uchimaru K, Matsuoka M, Matsumoto N, Hasegawa Y, Yamano Y. Mogamulizumab (Anti-CCR4) in HTLV-1-Associated Myelopathy. The New England journal of medicine. 2018 Feb 8:378(6):529-538. doi: 10.1056/NEJMoa1704827. Epub
[PubMed PMID: 29414279]
[52]
Chen YP, Wu ZJ, Liu W, Lu JP, Wang JC, Zhu WF, Chen FF, Zhong LH, Chen G. [Clinicopathological characteristics of adult T cell leukemia/lymphoma]. Zhonghua bing li xue za zhi = Chinese journal of pathology. 2019 Jan 8:48(1):11-16. doi: 10.3760/cma.j.issn.0529-5807.2019.01.003. Epub
[PubMed PMID: 30641639]
[53]
Sato T, Yagishita N, Tamaki K, Inoue E, Hasegawa D, Nagasaka M, Suzuki H, Araya N, Coler-Reilly A, Hasegawa Y, Tsuboi Y, Takata A, Yamano Y. Proposal of Classification Criteria for HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis Disease Activity. Frontiers in microbiology. 2018:9():1651. doi: 10.3389/fmicb.2018.01651. Epub 2018 Jul 25
[PubMed PMID: 30090093]
[54]
Ramos JM, Milla A, Sánchez V, Vergés M, Toro C, Gutiérrez F. [Prenatal screening for Trypanosoma cruzi and human T lymphotropic virus types 1 and 2 in pregnant Latin American women]. Enfermedades infecciosas y microbiologia clinica. 2009 Mar:27(3):165-7. doi: 10.1016/j.eimc.2008.04.006. Epub 2009 Feb 11
[PubMed PMID: 19306717]
[55]
Campos KR, Gonçalves MG, Caterino-de-Araujo A. Short Communication: Failures in Detecting HTLV-1 and HTLV-2 in Patients Infected with HIV-1. AIDS research and human retroviruses. 2017 Apr:33(4):382-385. doi: 10.1089/AID.2016.0191. Epub 2016 Nov 14
[PubMed PMID: 27750018]